Jamie L Croucher
Overview
Explore the profile of Jamie L Croucher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
123
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tetri L, Kolla V, Golden R, Iyer R, Croucher J, Choi J, et al.
Oncol Rep
. 2020 Apr;
44(1):263-272.
PMID: 32319659
Neuroblastomas (NBs) have heterogeneous clinical behavior, from spontaneous regression or differentiation to relentless progression. Evidence from our laboratory and others suggests that neurotrophin receptors contribute to these disparate behaviors. Previously,...
2.
Iyer R, Wehrmann L, Golden R, Naraparaju K, Croucher J, MacFarland S, et al.
Cancer Lett
. 2016 Jan;
372(2):179-86.
PMID: 26797418
Neuroblastoma (NB) is one of the most common and deadly childhood solid tumors. These tumors are characterized by clinical heterogeneity, from spontaneous regression to relentless progression, and the Trk family...
3.
Alferiev I, Iyer R, Croucher J, Adamo R, Zhang K, Mangino J, et al.
Biomaterials
. 2015 Mar;
51:22-29.
PMID: 25770994
Nanomedicine-based strategies have the potential to improve therapeutic performance of a wide range of anticancer agents. However, the successful implementation of nanoparticulate delivery systems requires the development of adequately sized...
4.
Iyer R, Croucher J, Chorny M, Mangino J, Alferiev I, Levy R, et al.
Cancer Lett
. 2015 Feb;
360(2):205-12.
PMID: 25684664
Neuroblastoma (NB) is the most common and deadly solid tumor in children. The majority of NB patients have advanced stage disease with poor prognosis, so more effective, less toxic therapy...
5.
Croucher J, Iyer R, Li N, Molteni V, Loren J, Gordon W, et al.
Cancer Chemother Pharmacol
. 2014 Nov;
75(1):131-41.
PMID: 25394774
Purpose: Neuroblastoma (NB) is one of the most common and deadly pediatric solid tumors. NB is characterized by clinical heterogeneity, from spontaneous regression to relentless progression despite intensive multimodality therapy....
6.
Brodeur G, Iyer R, Croucher J, Zhuang T, Higashi M, Kolla V
Expert Opin Ther Targets
. 2014 Jan;
18(3):277-92.
PMID: 24387342
Introduction: Neuroblastoma (NB) is the most common and deadly solid tumor in children. Despite recent improvements, the long-term outlook for high-risk NB is still < 50%. Further, there is considerable...